Travere Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 04/08/2026 | Mar 2026Filed 04/05/2026 | Sep 2025Filed 30/10/2025 | Jun 2025Filed 04/08/2026 | Mar 2025Filed 04/05/2026 | Sep 2024Filed 30/10/2025 | Jun 2024Filed 06/08/2025 | Mar 2024Filed 01/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $170 | $127 | $165 | $114 | $82 | $63 | $54 | $41 | |
| −$35 | −$37 | $26 | −$13 | −$41 | −$55 | −$70 | −$136 | |
| −$0.37 | −$0.40 | $0.28 | −$0.14 | −$0.47 | −$0.70 | −$0.91 | −$1.76 | |
| 93 | 92 | 103 | 89 | 88 | 78 | 78 | 77 |
Trend